Literature DB >> 11062028

CYP4B1 is a possible risk factor for bladder cancer in humans.

S Imaoka1, Y Yoneda, T Sugimoto, T Hiroi, K Yamamoto, T Nakatani, Y Funae.   

Abstract

In experimental animals such as rats and rabbits, CYP4B1 has an important role in mutagenic activation of procarcinogens in bladders. In human bladders, it is not clear whether CYP4B1 has such role or not. In the present study, human bladder microsomes activated 2-aminofluorene which is a typical substrate for CYP4B1 and is a bladder carcinogen. CYP4B1 was detected in the human bladder microsomes by immunoblotting. Furthermore, we developed a microassay for CYP4B1 mRNA by performing real-time RT-PCR. Using this method, CYP4B1 mRNA levels were assayed in transurethal resection samples from the bladders of patients with bladder tumors. The bladder-tumor patients had a significantly higher expression of CYP4B1 than the nonbladder tumor patients. These findings suggest that a high expression of CYP4B1 increases the risk of bladder tumor by activation of carcinogenic aromatic amines. This approach could be an important tool in the assessment of human bladder cancer risk. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062028     DOI: 10.1006/bbrc.2000.3740

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  ω- versus (ω-1)-hydroxylation: Cytochrome P450 4B1 sterics make the call.

Authors:  Emily E Scott
Journal:  J Biol Chem       Date:  2017-03-31       Impact factor: 5.157

3.  Suppression of cytochrome P450 4B1: An early event in adrenocortical tumorigenesis.

Authors:  Timothy D Murtha; Reju Korah; Tobias Carling
Journal:  Surgery       Date:  2016-11-16       Impact factor: 3.982

Review 4.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

5.  Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.

Authors:  Constanze Wiek; Eva M Schmidt; Katharina Roellecke; Marcel Freund; Mariko Nakano; Edward J Kelly; Wolfgang Kaisers; Vladimir Yarov-Yarovoy; Christof M Kramm; Allan E Rettie; Helmut Hanenberg
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

6.  Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.

Authors:  Ki Yeon Kim; Gwanghee Lee; Minsang Yoon; Eun Hye Cho; Chan-Sik Park; Moon Gyo Kim
Journal:  Mol Cells       Date:  2015-05-27       Impact factor: 5.034

7.  Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study.

Authors:  Saravanabavan Sayanthooran; Dhammika N Magana-Arachchi; Lishanthe Gunerathne; Tilak Abeysekera
Journal:  BMC Nephrol       Date:  2017-01-19       Impact factor: 2.388

8.  Integrative Analysis of Somatic Mutations in Non-coding Regions Altering RNA Secondary Structures in Cancer Genomes.

Authors:  Funan He; Ran Wei; Zhan Zhou; Leihuan Huang; Yinan Wang; Jie Tang; Yangyun Zou; Leming Shi; Xun Gu; Melissa J Davis; Zhixi Su
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

9.  Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

Authors:  Aimee M Johnson; Mary J O'Connell; Hiroshi Miyamoto; Jiaoti Huang; Jorge L Yao; Edward M Messing; Jay E Reeder
Journal:  BMC Urol       Date:  2008-04-23       Impact factor: 2.264

10.  Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.

Authors:  Yinmin Gu; Yi Ming Zou; Danqing Lei; Yuanjie Huang; Weidong Li; Zengnan Mo; Yanling Hu
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.